嘉和生物提交新上市申请 涉及重大收购与合并事项

财中社
16 Apr

嘉和生物(06998)发布公告,宣布公司已于2025年4月15日向联交所提交新上市申请。这一申请涉及多个方面,包括非常重大收购事项、合并附属公司与标的公司之间的交易,以及申请清洗豁免等。此外,公司还建议更改名称和增加法定股本,并计划采用一次性购股权计划。公告中提到,合并的完成需要满足特定的先决条件,并且联交所上市委员会未必会批准公司的新上市申请。如果新上市申请未获批准,合并协议将不会生效,进而影响...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10